Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Estey

Showing results (101-110 of 204) with videos related to

Pageof 21
Sort By:
Leukemia|May 17, 2003
Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemiaM B Thomas, C Koller, Y Yang, et al.
Investigational New Drugs|April 9, 2001
Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemiaF Giles, J Cortes, G Garcia-Manero, et al.
Leukemia|May 1, 1994
Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alphaA Ferrajoli, M Talpaz, T F Zipf, et al.
Leukemia|April 1, 1989
Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemiaE Estey, T L Smith, M J Keating, et al.
Cancer Research|June 1, 1987
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapyW Plunkett, J O Liliemark, T M Adams, et al.
Leukemia|April 9, 2016
Prediction of CR following a second course of '7+3' in patients with newly diagnosed acute myeloid leukemia not in CR after a first courseM Othus, S Mukherjee, M A Sekeres, et al.
Leukemia|January 17, 2003
Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNAI Jilani, E Estey, T Manshuri, et al.
Blood|January 7, 1998
Implications of potential cure in acute myelogenous leukemia: development of subsequent cancer and return to workM de Lima, S S Strom, M Keating, et al.
Leukemia & Lymphoma|March 28, 1998
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemiaS M Kornblau, H Kantarjian, S O'Brien, et al.
Acta Haematologica|January 1, 1987
Comparison of results of salvage therapy in adult acute myelogenous leukemiaM J Keating, E Estey, H M Kantarjian, et al.
Pageof 21

Showing results (101-110 of 204) with videos related to

Sort By:
Pageof 21
Leukemia|May 17, 2003
Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemiaM B Thomas, C Koller, Y Yang, et al.
Investigational New Drugs|April 9, 2001
Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemiaF Giles, J Cortes, G Garcia-Manero, et al.
Leukemia|May 1, 1994
Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alphaA Ferrajoli, M Talpaz, T F Zipf, et al.
Leukemia|April 1, 1989
Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemiaE Estey, T L Smith, M J Keating, et al.
Cancer Research|June 1, 1987
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapyW Plunkett, J O Liliemark, T M Adams, et al.
Leukemia|April 9, 2016
Prediction of CR following a second course of '7+3' in patients with newly diagnosed acute myeloid leukemia not in CR after a first courseM Othus, S Mukherjee, M A Sekeres, et al.
Leukemia|January 17, 2003
Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNAI Jilani, E Estey, T Manshuri, et al.
Blood|January 7, 1998
Implications of potential cure in acute myelogenous leukemia: development of subsequent cancer and return to workM de Lima, S S Strom, M Keating, et al.
Leukemia & Lymphoma|March 28, 1998
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemiaS M Kornblau, H Kantarjian, S O'Brien, et al.
Acta Haematologica|January 1, 1987
Comparison of results of salvage therapy in adult acute myelogenous leukemiaM J Keating, E Estey, H M Kantarjian, et al.
Pageof 21